These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 690025)

  • 1. Susceptibility of anaerobes to cefoxitin sodium and cephalothin.
    Sutter VL; Oberhammer I; Kwok YY; Finegold SM
    J Antimicrob Chemother; 1978 Jul; 4(B):41-6. PubMed ID: 690025
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility of anaerobes to cefoxitin and other cephalosporins.
    Tally FP; Jacobus NV; Bartlett JG; Gorbach SL
    Antimicrob Agents Chemother; 1975 Feb; 7(2):128-32. PubMed ID: 1137364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
    Brorson JE; Norrby R
    Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
    [No Abstract]   [Full Text] [Related]  

  • 4. Susceptibility of anaerobic bacteria to cofoxitin and related compounds.
    Bach VT; Roy I; Thadepalli H
    Antimicrob Agents Chemother; 1977 May; 11(5):912-3. PubMed ID: 879743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vivo comparison of cefoxitin, a semi-synthetic cephamycin, with cephalothin.
    Hamilton-Miller JM; Kerry DW; Brumfitt W
    J Antibiot (Tokyo); 1974 Jan; 27(1):42-8. PubMed ID: 4843049
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro susceptibility of bacteroidaceae to cefoxitin and cephalothin (author's transl)].
    Werner H; Firsching R; Krasemann C
    Infection; 1977; 5(1):13-6. PubMed ID: 856727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of clinical strains of bacteria to cefoxitin.
    Bremner DA
    N Z Med J; 1981 Sep; 94(691):173-4. PubMed ID: 6945507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins].
    Torres A; Aguirre M; Ales JM
    Rev Clin Esp; 1979 Nov; 155(4):249-52. PubMed ID: 542674
    [No Abstract]   [Full Text] [Related]  

  • 12. Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins.
    Dubois J; Pechère JC
    Infection; 1978; 6(6):266-70. PubMed ID: 730395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of cefoxitin sodium: clinical implications.
    Stamboulian D; Sarachian B
    J Antimicrob Chemother; 1978 Jul; 4(B):65-8. PubMed ID: 690026
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of cefoperazone's in vitro antibacterial activity, in comparison with other cephalosporins, on 512 gram-negative bacterial strains.
    Dainelli B; Magni A; Maragoni F; Berlutti F; Thaller MC; Filadoro F
    G Batteriol Virol Immunol; 1981; 74(1-6):8-14. PubMed ID: 6458528
    [No Abstract]   [Full Text] [Related]  

  • 15. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative staphylolytic activity of cefoxitin, cephalothin and cefuroxime.
    Rogers DT; Russell AD
    J Antimicrob Chemother; 1980 Jul; 6(4):511-7. PubMed ID: 7430014
    [No Abstract]   [Full Text] [Related]  

  • 17. Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin.
    Moellering RC; Dray M; Kunz LJ
    Antimicrob Agents Chemother; 1974 Sep; 6(3):320-3. PubMed ID: 15830480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin.
    Hoeprich PD; Huston AC
    J Infect Dis; 1976 Jun; 133(6):681-5. PubMed ID: 778303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.
    Barry AL; Thornsberry C; Jones RN; Fuchs PC; Gavan TL; Gerlach EH
    Am J Clin Pathol; 1978 Dec; 70(6):909-13. PubMed ID: 727174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.
    Drulak MW; Chow AW
    Antimicrob Agents Chemother; 1981 Nov; 20(5):683-5. PubMed ID: 6275782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.